Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 Apr;72(4):525–533. doi: 10.1002/acr.23878

Table 2.

Characteristics of California Lupus Epidemiology Study (CLUES) participants, 2015–2018, by Adverse Childhood Experiences (ACE) level

Overall CLUES Participants CLUES Participants with ACE Responses
ACE Level
Demographics ACE 0 ACE 1 ACE 2–3 ACE ≥4 p-value *
n, (row %) 269 99 (36.8) 59 (21.9) 59 (21.9) 52 (19.3)
Age, mean (sd) 45.2 (13.9) 43.7 (15.3) 43.6 (13.5) 46.0 (13.2) 48.9 (11.7) 0.02
Women 241 (89.6) 82 (82.8) 56 (94.9) 53 (89.8) 50 (96.2) 0.03
Race/ethnicity 0.001
Non-Hispanic White 85 (31.6) 25 (25.3) 20 (33.9) 24 (40.7) 16 (30.8)
Latino 69 (25.7) 19 (19.2) 19 (32.2) 16 (27.1) 15 (28.9)
Non-Hispanic African American 32 (11.9) 8 (8.1) 5 (8.5) 7 (11.9) 12 (23.1)
Asian/Pacific Islander 79 (29.4) 45 (45.5) 15 (25.4) 12 (20.3) 7 (13.5)
Other 4 (1.5) 2 (2.0) 0 0 2 (3.9)
Education 0.02
High school or less 42 (15.6) 9 (9.1) 14 (23.7) 8 (13.6) 11 (21.2)
Some college/AA 90 (33.5) 28 (28.3) 17 (28.8) 27 (45.8) 18 (34.6)
College graduate 137 (50.9) 62 (62.6) 28 (47.5) 24 (40.7) 23 (44.2)
Disease duration, mean (sd) 16.7 (10.4) 16.2 (11.0) 16.0 (10.9) 18.0 (9.0) 17.1 (10.2) 0.41
Childhood onset <18 years 44 (16.4) 24 (24.2) 10 (17.0) 8 (13.6) 2 (3.9) 0.01
Lupus Nephritis 120 (44.6) 50 (50.5) 32 (54.2) 24 (40.7) 14 (26.9) 0.01

AA – Associate Degree.

Note: cells are n (column %), unless indicated.

*

P-values for age and disease duration based on linear contrasts for trend. All others from chi-square tests. Comparison to ACE = 0.